Skip to main content

Rajasthan

 

Clinical courses

 

Clinical research courses

  • PharmaTutor Magazine - May 2015 is released | Read online and Subscribe

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • Applications invited for Pharma Management faculties at IIHMR University

    IIHMR University Is a specialised Research University in management research, postgraduate education and training exclusively in the health sector. The IIHMR University has established the discipline of health management and set the national agenda lor policy and program and health systems research in the health sector. It is a WHO Collaborating Centre for district health systems and designated as an Institute of Excedence in India for training and capacity.

    Invites Applications For Associate Professor AND Assistant Professor In Following Areas:

    Post: Associate Professor, Assistant Professor

  • AN INSIGHT ON NUTRACEUTICALS
  • PharmaTutor Magazine - April 2015 is released | Read online and Subscribe

  • Opportunity for Assistant Professor - Pharmacy in MSU

    Mohanlal Sukhadia University (erstwhile Udaipur University) at Udaipur is a State University established by an Act in the year 1962 to cater the needs of higher education in Southern Rajasthan. The University is located in Aravalli Hill Area largely dominated by tribal populations. Endowed with rich cultural heritage, natural resources and beautiful landscape, Udaipur is a world renowned tourist attraction.

    On-line applications are invited for appointment of teaching faculties on regular basis for the following posts:

    Post: Assistant Professor

  • Vacancies for B.Pharm/D.Pharm as Logistic Manager, Consultant in National Health Mission

    National Health Mission (NHM), Rajasthan State Health Society, invites applications for various positions of Managers/Consultants/Ofificers/Coordinators and Assistants at State HQ on contractual basis under National Rural Health Mission (NRHM) Rajasthan.

    The details of various positions, required essential qualifications & experience, maximum age limit etc.are as under:

    Post: Logistic Manager, Consultant

  • Admission open for MBA Pharmaceutical Management at IIHMR University, Jaipur

    The IIHMR University, Jaipur formerly known as Institute of Health Management Research (IIHMR), Jaipur the premier University in Hospital, Health, Pharmaceutical and Rural Management, has made a phenomenal contribution in the career of its alumni. Provides excellent opportunities in education, training, research and consultancy in healthcare and hospital Services.

    ENQUIRE TODAY>>

    A Unique Research and Postgraduate University in Health Sector Established Under IIHMR Private University Act 2014, Government of Rajasthan
    Formerly known as Institute of Health Management Research (IIHMR), Jaipur A WHO Collaborating Centre for District Health Systems based on Primary Health Care

    MBA PHARMACEUTICAL MANAGEMENT

    Eligibility:
    · Recognized Bachelor's Degree in Medicine/Pharmacy/ Biotechnology/Science/Management with at least 50% marks in aggregate.
    · Valid Score of CAT/MAT/CMAT/ATMA/XAT/GPAT.
    · Working professionals with at least two years experience in Pharmaceutical or Health sector are encouraged to apply and are exempted from the scores of management aptitude tests.

    Some of leading recruiters

    IIHMR PHARMA RECRUITMENT: Abott, Cadila Pharma, Ranbaxy, Sun Pharma, Thumbay, Medanta, Evalueserve, GVK

    ENQUIRE TODAY>>

    Address:
    1, Prabhu Dayal Marg, Sanganer Airport, Jaipur - 302029
    Phone: 91-141-3924700, 2791431-32
    Fax: 91-141-3924738
  • PharmaTutor Magazine - March 2015 is released | Read online and Subscribe

Subscribe to Rajasthan